Cas:649773-85-3 3-[3-(1,3-benzodioxol-5-yloxy)-2-oxopyrrolidin-1-yl]benzoic acid manufacturer & supplier

Chemical Name:3-[3-(1,3-benzodioxol-5-yloxy)-2-oxopyrrolidin-1-yl]benzoic acid

CAS.NO:649773-85-3

Synonyms:Benzoic acid,3-[3-(1,3-benzodioxol-5-yloxy)-2-oxo-1-pyrrolidinyl]

Molecular Formula:C₁₈H₁₅NO₆

Molecular Weight:341.31500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:85.30000

Exact Mass:341.09000

LogP:2.36280

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzoic acid,3-[3-(1,3-benzodioxol-5-yloxy)-2-oxo-1-pyrrolidinyl] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid,3-[3-(1,3-benzodioxol-5-yloxy)-2-oxo-1-pyrrolidinyl] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzoic acid,3-[3-(1,3-benzodioxol-5-yloxy)-2-oxo-1-pyrrolidinyl] Use and application,Benzoic acid,3-[3-(1,3-benzodioxol-5-yloxy)-2-oxo-1-pyrrolidinyl] technical grade,usp/ep/jp grade.

Related News: This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs. 3-[3-(1,3-benzodioxol-5-yloxy)-2-oxopyrrolidin-1-yl]benzoic acid manufacturer ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. 3-[3-(1,3-benzodioxol-5-yloxy)-2-oxopyrrolidin-1-yl]benzoic acid supplier Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. 3-[3-(1,3-benzodioxol-5-yloxy)-2-oxopyrrolidin-1-yl]benzoic acid vendor This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs. 3-[3-(1,3-benzodioxol-5-yloxy)-2-oxopyrrolidin-1-yl]benzoic acid factory In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.